QuickView for Cytochrome P450, E-class, group II (biogroup)

1. Cell types defined by levels of Sox9 during irradiation-induced crypt regeneration
2. Livers, lungs, and spleens of GBA[D409V]/null Gaucher disease mice treated with glucocerebrosidases
3. Gene regulation by the transcription factor PPARα in human hepatocytes
4. Expression in hepatic cells expressing or not expressing Foxl1
5. Brain and liver of C57BL/6J, DBA2/J, and 129S2 mouse strains at 3 developmental timepoints

There were no matches for Cytochrome P450, E-class, group II

1. Rituximab, Lenalidomide, and Ibrutinib in Treating Patients With Previously Untreated Stage II-IV Fo…
2. Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follic…
3. Phase II Pharmacokinetics Study of CAM2038
4. Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase …
5. Phase II Study of TAK228 in Relapsed Lymphoma